Health Care/Hospital
Elliott Publishes Letter on GlaxoSmithKline
Elliott believes GSK has a substantial value creation opportunity – 45% upside in its share price – ahead of Consumer Health separation and greater beyond Despite its strengths, GSK has a poor record of operational execution and value creation, leading to scepticism about the Company's future, an...
2021-07-01 14:45
2227
European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine
EDENKOBEN, Germany, July 1, 2021 /PRNewswire/ – European Wellness Biomedical Group (European Wellness) through its educational arm, European Wellness Academy (EWA), has signed a Letter of Intent (LOI) withZhifu People's Government of Yantai City,Shandong Province, China to establish the first In...
2021-07-01 08:00
4979
Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories
Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...
2021-07-01 08:00
2227
Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints
SINGAPORE, July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusiveAsia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. ...
2021-07-01 08:00
6068
IMG Announces Start of Fifth 'Leave Your Mark' Global Outreach Essay Contest
INDIANAPOLIS, July 1, 2021 /PRNewswire/ -- International Medical Group (IMG) is proud to announce the start of their fifth Leave Your Mark essay contest. Initially started in 2017, the Leave Your Mark contest is designed to support and invest in causes addressed by mission and social good organiz...
2021-07-01 03:17
2118
Built on VeChainThor, VeTrust Is Now Adopted By Local Chinese Government, Helping 300k+ Citizens Return To Normalcy
SHANGHAI, June 30, 2021 /PRNewswire/ -- On the 9th of September 2020 during the on-going impact of the COVID-19 pandemic,VeChain, in conjunction with DNV, introduced the blockchain-based risk self-assessment application, VeTrust. Built on the VeChainThor public blockchain, it combines DNV's infec...
2021-06-30 20:00
4331
Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines
Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global markets MENLO PARK, Calif., June 30, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation ...
2021-06-30 20:00
2775
Mentice receives order of total SEK 5.9 million from Baylis Medical Company
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement withBaylis Medical Company ("Baylis")to provide simulation solutions. Based on t...
2021-06-30 18:19
1792
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) * Pending conditional regulatory approvals, Clover expects to commence product launch of SCB-2019 (CpG 1018/Alum) by the end of 2021 CHENGDU,...
2021-06-30 16:00
6186
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility
* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022 * Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data, potential payments upon...
2021-06-30 16:00
3209
Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions,appoints Gunilla Andersson as CFO, effective September 1st, 2021. Mentice AB is pleased to announce the appoin...
2021-06-30 15:06
1924
Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Airlines has approved the Envirotainer Releye® RLP for usage on their aircrafts. With this approval, China Airlines ...
2021-06-30 14:48
2351
AXA offers free personal accident protection coverage up to HKD600,000
HONG KONG, June 30, 2021 /PRNewswire/ -- AXA Hong Kong ("AXA") announces the launch of AXA "Support Local Tourism" Programme ("Programme"). From 1 July to31 December 2021, Hong Kong citizens aged between 6 months to 85 years old who have joined any registered local group tours organised by a lice...
2021-06-30 14:18
2514
Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease
Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations BRISTOL, England, June 30, 2021 /PRNewswire/ -- Bioinduction Ltd., a company developing an innovative and disruptive patient-centric Deep Brain Stimulation (DBS) platform s...
2021-06-30 14:00
1632
New Welch Allyn® PanOptic™ Plus Ophthalmoscope and Welch Allyn® MacroView® Plus Otoscope Give Caregivers Better, Bolder, Brighter Views
SINGAPORE, June 30, 2021 /PRNewswire/ -- Hillrom today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™ Plus Ophthalmoscope and the Welch Allyn® MacroView® Plus Otoscope. The new devices represent advancements...
2021-06-30 09:15
6471
Subcutaneously Injected PD-L1 Antibody Envafolimab (KN035) Obtained Its Second Orphan Drug Designation From The U.S. FDA
SUZHOU, China, June 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to envafolimab (KN035), a recombinant humanized PD-L1 single-domain antibody independently invented by Alphamab Onco...
2021-06-30 08:55
9596
GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)
* GSK Singapore has signed an Advance Purchase Agreement with the Government ofSingapore for sotrovimab * Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization * Announcement follow...
2021-06-30 06:30
3173
Picarro Expands Gas Concentration Analyzer Family to Enable Continuous Monitoring of Ambient Ethylene Oxide Emissions
SANTA CLARA, Calif., June 29, 2021 /PRNewswire/ -- Picarro, Inc., a leading provider of gas concentration and stable isotope analyzers and systems for scientific and industrial applications, today announced the availability of the G2920 Ambient Ethylene Oxide (EtO) gas concentration analyzer. EtO ...
2021-06-29 22:10
2507
Cynosure Celebrates 30 Years of Innovation
Aesthetics leader recognizes milestone with focus on future skin aesthetics innovation to help reveal the Beautiful Energy within everyone WESTFORD, Mass., June 29, 2021 /PRNewswire/ -- Since 1991, Cynosure has been a leader in the beauty aesthetics space, creating a comprehensive range of exper...
2021-06-29 21:00
2260
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients BRUSSELS and CASTRES, France, June 29, 2021 /PRNewswire/ -- European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic part...
2021-06-29 20:13
2475
Week's Top Stories
Most Reposted
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 299 media titles]
2026-06-04 23:55
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 292 media titles]
2026-06-05 15:00Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 291 media titles]
2026-06-05 19:08
FPT and NVIDIA Collaborate to Release the Nemotron Personas Vietnam Datasets
[Picked up by 276 media titles]
2026-06-05 17:34
Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Most Read
WePlay Korea's 4th Anniversary Celebration Kicks Off, Joining Hands with "Hello Panda-哈啰潘达" to Create Fu Bao Themed Space Decorations
2026-06-01 12:00
7003
NYSE Content Update: FedEx Freight to List on the NYSE + Join S&P 500
2026-06-01 21:32
6197
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2026
2026-06-02 15:33
5723
Mizuho becomes First Japanese Bank to Adopt SAP Multi-Bank Connectivity Solution
2026-06-02 15:00
5423
